S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
A Breakout Stock Is On The Way (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
A Breakout Stock Is On The Way (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
This Stock's Getting Attention (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
A Breakout Stock Is On The Way (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
A Breakout Stock Is On The Way (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
This Stock's Getting Attention (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
A Breakout Stock Is On The Way (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
A Breakout Stock Is On The Way (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
This Stock's Getting Attention (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
A Breakout Stock Is On The Way (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
A Breakout Stock Is On The Way (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
This Stock's Getting Attention (Ad)
NASDAQ:BKYI

BIO-key International - BKYI Stock Forecast, Price & News

$1.84
-0.33 (-15.21%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.80
$2.16
50-Day Range
$1.62
$2.17
52-Week Range
$1.59
$3.80
Volume
109,068 shs
Average Volume
48,204 shs
Market Capitalization
$15.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BIO-key International MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
0.92% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.05mentions of BIO-key International in the last 14 days
Based on 9 Articles This Week
Insider Trading
Acquiring Shares
$7,820 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.29 out of 5 stars

Computer And Technology Sector

645th out of 659 stocks

Computer & Office Equipment Industry

14th out of 14 stocks

BKYI stock logo

About BIO-key International (NASDAQ:BKYI) Stock

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

BIO-key International Trading Down 15.2 %

NASDAQ:BKYI traded down $0.33 during mid-day trading on Friday, reaching $1.84. 109,068 shares of the stock were exchanged, compared to its average volume of 48,204. BIO-key International has a 1-year low of $1.59 and a 1-year high of $3.80. The business's fifty day simple moving average is $1.80 and its 200 day simple moving average is $2.04. The stock has a market capitalization of $15.49 million, a PE ratio of -2.79 and a beta of 0.80. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.54 and a current ratio of 3.96.

BIO-key International (NASDAQ:BKYI - Get Rating) last announced its earnings results on Monday, May 16th. The technology company reported ($0.12) earnings per share (EPS) for the quarter. The firm had revenue of $1.94 million for the quarter. BIO-key International had a negative return on equity of 31.11% and a negative net margin of 100.91%.

Receive BKYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter.

BKYI Stock News Headlines

BIO-key Intl: Q1 Earnings Insights
See More Headlines
Receive BKYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter.

BKYI Company Calendar

Last Earnings
5/16/2022
Today
8/12/2022
Next Earnings (Confirmed)
8/12/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Computer & office equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:BKYI
Employees
51
Year Founded
N/A

Profitability

Net Income
$-5,070,000.00
Net Margins
-100.91%
Pretax Margin
-100.91%

Debt

Sales & Book Value

Annual Sales
$5.11 million
Book Value
$1.99 per share

Miscellaneous

Free Float
7,609,000
Market Cap
$15.49 million
Optionable
Not Optionable
Beta
0.80














BKYI Stock - Frequently Asked Questions

How have BKYI shares performed in 2022?

BIO-key International's stock was trading at $2.21 at the beginning of 2022. Since then, BKYI shares have decreased by 16.7% and is now trading at $1.84.
View the best growth stocks for 2022 here
.

When is BIO-key International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 12th 2022.
View our BKYI earnings forecast
.

How were BIO-key International's earnings last quarter?

BIO-key International, Inc. (NASDAQ:BKYI) released its quarterly earnings results on Monday, May, 16th. The technology company reported ($0.12) earnings per share for the quarter. The technology company earned $1.94 million during the quarter. BIO-key International had a negative trailing twelve-month return on equity of 31.11% and a negative net margin of 100.91%.

What guidance has BIO-key International issued on next quarter's earnings?

BIO-key International updated its FY 2022 earnings guidance on Friday, August, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $10.00 million-$13.00 million, compared to the consensus revenue estimate of $12.00 million.

What other stocks do shareholders of BIO-key International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BIO-key International investors own include Biocept (BIOC), T2 Biosystems (TTOO), iBio (IBIO), Onconova Therapeutics (ONTX), Acasti Pharma (ACST), Co-Diagnostics (CODX), Heat Biologics (HTBX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV) and Inovio Pharmaceuticals (INO).

What is BIO-key International's stock symbol?

BIO-key International trades on the NASDAQ under the ticker symbol "BKYI."

Who are BIO-key International's major shareholders?

BIO-key International's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Group One Trading L.P. (0.00%). Insiders that own company stock include James David Sullivan, Michael W Depasquale and Michael W Depasquale.
View institutional ownership trends
.

How do I buy shares of BIO-key International?

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BIO-key International's stock price today?

One share of BKYI stock can currently be purchased for approximately $1.84.

How much money does BIO-key International make?

BIO-key International (NASDAQ:BKYI) has a market capitalization of $15.49 million and generates $5.11 million in revenue each year. The technology company earns $-5,070,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis.

How can I contact BIO-key International?

BIO-key International's mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL NJ, 07719. The official website for the company is www.bio-key.com. The technology company can be reached via phone at (732) 359-1100, via email at bkyi@catalyst-ir.com, or via fax at 732-359-1101.

This page (NASDAQ:BKYI) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.